TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year April 20, 2012
TCL Archive After Congressional Inquiry, NCI Posts Ambiguous Statement On Abortion And Breast Cancer Risk December 13, 2002
TCL Archive Three Bomb Threats At NIH In One Week result In Evacuations, Investigations August 2, 1996
